MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma.

Technol Cancer Res Treat · 2022 · PMC9772976 · PMID 36537076

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The blood levels of miR-3201 were significantly decreased in patients responding to therapy at all the considered time points ( P = .026), showing an increasing trend of expression over time in PRPD patients.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.